United States
Germany
Japan
United Kingdom
China
CNY 3,990.00
2周
Antibodies
HRAS mouse monoclonal antibody, clone OTI1A1 (formerly 1A1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,990.00
2周
CNY 3,990.00
2周
HRAS mouse monoclonal antibody,clone OTI2A1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
HRAS mouse monoclonal antibody,clone OTI1C8
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
HRAS mouse monoclonal antibody,clone OTI1C2
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Rabbit Polyclonal Anti-HRAS Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
p21 Ras (HRAS) mouse monoclonal antibody, clone H-Ras-03, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Human |
Rabbit Polyclonal Anti-HRAS Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
HRAS mouse monoclonal antibody, clone OTI1F2 (formerly 1F2)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
HRAS mouse monoclonal antibody,clone OTI1G8
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
HRAS mouse monoclonal antibody, clone OTI1H3 (formerly 1H3)
| Applications | WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
活动过滤器
clear Category
- Antibodies
优化搜索结果
Reactivities
Antibody Hosts
Conjugates
Clonalities
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (45)
- Axon guidance (45)
- B cell receptor signaling pathway (45)
- Bladder cancer (45)
- Chemokine signaling pathway (45)
- Chronic myeloid leukemia (45)
- Endocytosis (45)
- Endometrial cancer (45)
- ErbB signaling pathway (45)
- Fc epsilon RI signaling pathway (45)
- Focal adhesion (45)
- Gap junction (45)
- Glioma (45)
- GnRH signaling pathway (45)
- Insulin signaling pathway (45)
- Long-term depression (45)
- Long-term potentiation (45)
- MAPK signaling pathway (45)
- Melanogenesis (45)
- Melanoma (45)
- Natural killer cell mediated cytotoxicity (45)
- Neurotrophin signaling pathway (45)
- Non-small cell lung cancer (45)
- Pathways in cancer (45)
- Prostate cancer (45)
- Regulation of actin cytoskeleton (45)
- Renal cell carcinoma (45)
- T cell receptor signaling pathway (45)
- Thyroid cancer (45)
- Tight junction (45)
- VEGF signaling pathway (45)
